Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice DOI Creative Commons

Josephine M. Kanta,

Luisa Deisen,

Kornelia Johann

et al.

Molecular Metabolism, Journal Year: 2023, Volume and Issue: 74, P. 101760 - 101760

Published: June 24, 2023

Medium chain fatty acids (MCFAs), which are with lengths of 8-12 carbon atoms, have been shown to reduce food intake in rodents and humans, but the underlying mechanisms unknown. Unlike most other acids, MCFAs absorbed from intestine into portal vein enter first liver. We thus hypothesized that trigger release hepatic factors appetite.The liver transcriptome mice were orally administered as C8:0 triacylglycerol (TG) was analyzed. Circulating growth/differentiation factor 15 (GDF15), tissue Gdf15 mRNA investigated after acute oral gavage or C10:0 TG mice. Effects subchronic administration on body weight determined lacking either receptor for GDF15, GDNF Family Receptor Alpha Like (GFRAL), GDF15.Hepatic small intestinal expression circulating GDF15 increased ingestion MCFAs, while typical dietary long-chain (LCFAs) had no effect. Plasma levels also MCFA intake, indicating addition liver, contributes rise GDF15. Acute provision decreased over 24 h compared a LCFA-containing bolus, this anorectic effect required receptor, GFRAL. Moreover, reduced 7 days, an blunted GFRAL.We identified novel nutritional approach increases revealed GDF15-GFRAL axis is full MCFAs.

Language: Английский

Aging Hallmarks and the Role of Oxidative Stress DOI Creative Commons
Edio Maldonado, Sebastián Morales, Fabiola Urbina

et al.

Antioxidants, Journal Year: 2023, Volume and Issue: 12(3), P. 651 - 651

Published: March 6, 2023

Aging is a complex biological process accompanied by progressive decline in the physical function of organism and an increased risk age-related chronic diseases such as cardiovascular diseases, cancer, neurodegenerative diseases. Studies have established that there exist nine hallmarks aging process, including (i) telomere shortening, (ii) genomic instability, (iii) epigenetic modifications, (iv) mitochondrial dysfunction, (v) loss proteostasis, (vi) dysregulated nutrient sensing, (vii) stem cell exhaustion, (viii) cellular senescence, (ix) altered communication. All these alterations been linked to sustained systemic inflammation, mechanisms contribute timing not clearly determined yet. Nevertheless, dysfunction one most important contributing process. Mitochondria primary endogenous source reactive oxygen species (ROS). During ATP production elevated ROS together with antioxidant defense. Elevated levels can cause oxidative stress severe damage cell, organelle membranes, DNA, lipids, proteins. This contributes phenotype. In this review, we summarize recent advances emphasis on production.

Language: Английский

Citations

216

GDF15 promotes weight loss by enhancing energy expenditure in muscle DOI Creative Commons
Dongdong Wang, Logan K. Townsend,

Geneviève J. DesOrmeaux

et al.

Nature, Journal Year: 2023, Volume and Issue: 619(7968), P. 143 - 150

Published: June 28, 2023

Caloric restriction that promotes weight loss is an effective strategy for treating non-alcoholic fatty liver disease and improving insulin sensitivity in people with type 2 diabetes1. Despite its effectiveness, most individuals, usually not maintained partly due to physiological adaptations suppress energy expenditure, a process known as adaptive thermogenesis, the mechanistic underpinnings of which are unclear2,3. Treatment rodents fed high-fat diet recombinant growth differentiating factor 15 (GDF15) reduces obesity improves glycaemic control through glial-cell-derived neurotrophic family receptor α-like (GFRAL)-dependent suppression food intake4-7. Here we find that, addition suppressing appetite, GDF15 counteracts compensatory reductions eliciting greater (NAFLD) compared caloric alone. This effect maintain expenditure during calorie requires GFRAL-β-adrenergic-dependent signalling axis increases acid oxidation calcium futile cycling skeletal muscle mice. These data indicate therapeutic targeting GDF15-GFRAL pathway may be useful maintaining restriction.

Language: Английский

Citations

118

Mitochondrial stress and mitokines in aging DOI Creative Commons
Johannes Burtscher, Afsaneh Soltany, Nishant P. Visavadiya

et al.

Aging Cell, Journal Year: 2023, Volume and Issue: 22(2)

Published: Jan. 15, 2023

Abstract Mitokines are signaling molecules that enable communication of local mitochondrial stress to other mitochondria in distant cells and tissues. Among those FGF21, GDF15 (both expressed the nucleus) several mitochondrial‐derived peptides, including humanin. Their responsiveness induces mitokine‐signaling response for example exercise, following challenges skeletal muscle. Such is emerging as an important mediator exercise‐derived dietary strategy‐related molecular systemic health benefits, healthy aging. A compensatory increase mitokine synthesis secretion could preserve function overall cellular vitality. Conversely, resistance against actions may also develop. Alterations mitokine‐levels, therefore mitokine‐related inter‐tissue cross talk, associated with general aging processes influence development age‐related chronic metabolic, cardiovascular neurological diseases; whether these changes contribute or represent “rescue factors” remains be conclusively shown. The aim present review summarize expanding knowledge on mitokines, potential modulate them by lifestyle their involvement diseases. We highlight importance well‐balanced preventive therapeutic properties maintaining homeostasis sensitivity but risks arising from dysregulation mitokines. While reduced levels impair inter‐organ crosstalk, excessive concentrations can have deleterious consequences conditions such cancer heart failure. Preservation achieved regular exercise increased lifespan.

Language: Английский

Citations

58

Adipose tissue is a source of regenerative cells that augment the repair of skeletal muscle after injury DOI Creative Commons

Quentin Sastourné-Arrey,

Maxime Mathieu,

Xavier Contreras

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Jan. 5, 2023

Abstract Fibro-adipogenic progenitors (FAPs) play a crucial role in skeletal muscle regeneration, as they generate favorable niche that allows satellite cells to perform efficient regeneration. After injury, FAP content increases rapidly within the injured muscle, origin of which has been attributed their proliferation itself. However, recent single-cell RNAseq approaches have revealed phenotype and functional heterogeneity FAPs, raising question how this differentiation regenerative subtypes occurs. Here we report FAP-like residing subcutaneous adipose tissue (ScAT), stromal (ASCs), are released from ScAT response injury. Additionally, find ASCs infiltrate damaged via platelet-dependent mechanism thus contribute heterogeneity. Moreover, show either blocking infiltration or removing source impair Collectively, our data reveal is an unsuspected physiological reservoir support underlining beneficial relationship between fat.

Language: Английский

Citations

47

A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction DOI Open Access
Danbi Jo, Gwangho Yoon, Oh Yoen Kim

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2022, Volume and Issue: 147, P. 112636 - 112636

Published: Jan. 17, 2022

Sarcopenia characterized by reduced skeletal muscle mass and decreased strength is increasing in prevalence globally. The pathophysiology of sarcopenia related to various factors including hormonal imbalance, increased intracellular oxidative stress, reduction food intake, advanced age, low body index, physical activity. Recently, has been reported be associated with cognitive decline, the common risk between memory loss were observed cohort studies. Many researchers suggested that vascular disorder, such as atherosclerosis alteration mechanisms caused changes myokine secretion. We herein review emerging evidence on strong link impairment sarcopenia, focusing secretion dysfunction, provide an understanding relevant crucial determinants decline sarcopenia.

Language: Английский

Citations

51

The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not? DOI Creative Commons
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

et al.

Diagnostics, Journal Year: 2022, Volume and Issue: 12(9), P. 2051 - 2051

Published: Aug. 24, 2022

Coronavirus disease 2019 (COVID-19) is primarily caused by various forms of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants. COVID-19 characterized hyperinflammation, oxidative stress, multi-organ injury (MOI)-like lung (ALI) and distress (ARDS). Different biomarkers are used in the assessment severity including D-dimer, ferritin, lactate dehydrogenase (LDH), hypoxia-inducible factor (HIF). Interestingly, growth differentiation 15 (GDF15) has recently become a potential biomarker correlated with severity. Thus, this critical review aimed to determine association between GDF15 COVID-19. The perfect function remains not well-recognized; nevertheless, it plays vital role controlling cell growth, apoptosis inflammatory activation. Furthermore, may act as anti-inflammatory pro-inflammatory signaling diverse cardiovascular complications. release activated factors cytokines macrophage colony-stimulating (M-CSF), angiotensin II (AngII) p53. Therefore, higher expression might compensatory mechanism stabilize counteract dysregulated reactions. In conclusion, an cytokine that could be associated Increased against hyperinflammation exaggerated immune response Experimental, preclinical large-scale clinical studies warranted regard.

Language: Английский

Citations

46

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of… DOI Creative Commons
Aurélie Ladang, Charlotte Beaudart, Jean‐Yves Reginster

et al.

Calcified Tissue International, Journal Year: 2023, Volume and Issue: 112(2), P. 197 - 217

Published: Jan. 12, 2023

Abstract In clinical trials, biochemical markers provide useful information on the drug’s mode of action, therapeutic response and side effect monitoring can act as surrogate endpoints. pharmacological intervention development for sarcopenia management, there is an urgent need to identify biomarkers measure in trials that could be used future practice. The objective current consensus paper a clear list musculoskeletal health aging recommended measured Phase II III evaluating new chemical entities treatment. A working group European Society Clinical Economic Aspects Osteoporosis, Osteoarthritis Musculoskeletal Diseases (ESCEO) proposed classifying into 2 series: status causal factors. For series 1, agreed 4 should assessed or (i.e., Myostatin-Follistatin, Brain Derived Neurotrophic Factor, N -terminal Type Procollagen Serum Creatinine Cystatin C Ratio – Sarcopenia Index). 2, 6 hormones insulin-like growth factor-1 (IGF-I), dehydroepiandrosterone sulphate, cortisol, inflammatory C-reactive protein (CRP), interleukin-6 tumor necrosis factor- α ), IGF-I CRP). also optional may insights action therapies. Further research methods marker assays lead evolution these recommendations.

Language: Английский

Citations

39

Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review DOI Open Access
Paulina Małkowska, Marek Sawczuk

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(13), P. 11156 - 11156

Published: July 6, 2023

Physical activity and exercise training have numerous health benefits, including the prevention management of chronic diseases, improvement cardiovascular health, enhancement mental well-being. However, effectiveness programs can vary widely among individuals due to various factors, such as genetics, lifestyle, environment. Thus, identifying reliable biomarkers evaluate physical personalize is crucial. Cytokines are signaling molecules produced by immune cells that play a vital role in inflammation tissue repair. In recent years, there has been increasing interest potential use cytokines for evaluating effectiveness. This review article aims provide an overview cytokines, their biomarkers, methods measuring cytokine levels, factors affect levels. The also discusses benefits using monitoring muscle damage inflammation, personalized based on responses. We believe holds great promise optimizing improving overall outcomes.

Language: Английский

Citations

37

Overview of growth differentiation factor 15 in metabolic syndrome DOI Creative Commons
Mohamed Asrih, Shibo Wei,

Thanh Thuy Nguyen

et al.

Journal of Cellular and Molecular Medicine, Journal Year: 2023, Volume and Issue: 27(9), P. 1157 - 1167

Published: March 29, 2023

Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor-β (TGF-β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies such as obesity cardiovascular diseases. considered to be regulator, although its precise mechanisms action remain determined. Glial cell-derived neurotrophic family receptor alpha-like (GRAL), located in hindbrain, identified for signals through coreceptor tyrosine kinase (RET). Administration analogues preclinical studies using various animal models consistently shown induce weight loss reduction food intake. GDF15, therefore, represents an attractive target combat current global epidemic. In this article, we review knowledge on involvement syndrome.

Language: Английский

Citations

30

GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice DOI Open Access

K. Fichtner,

Hermann Kalwa, Miaomiao Lin

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(5), P. 734 - 734

Published: March 4, 2024

In 2017, four independent publications described the glial cell-derived neurotrophic factor (GDNF) receptor alpha-like (GFRAL) as for growth differentiation 15 (GDF15, also MIC-1, NAG-1) with an expression exclusively in mice brainstem area postrema (AP) and nucleus tractus solitarii (NTS) where it mediates effects of GDF15 on reduction food intake body weight. is a cell stress cytokine widespread pleiotropic effects, which both seem to be contrast reported highly specialized localization its receptor. This discrepancy prompts us re-evaluate pattern GFRAL brain peripheral tissues mice. this detailed immunohistochemical study, we provide evidence more distribution Apart from AP/NTS region, GFRAL-immunoreactivity was found prefrontal cortex, hippocampus, arcuatus including liver, small intestine, fat, kidney muscle tissues. expression, not taken into consideration so far, may explain multiple GDF-15 that are yet assigned GFRAL. Furthermore, our results could relevant development novel pharmacological therapies physical mental disorders related image intake, such eating disorders, cachexia obesity.

Language: Английский

Citations

16